Tissue transglutaminase and the progression of human renal scarring

Timothy S. Johnson, Ahmed F. El-Koraie, N. Skill, Nahed M. Baddour, A. Meguid El Nahas, Melvin Njloma, Ahmed G. Adam, Martin Griffin

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Experimental renal scarring indicates that tissue transglutaminase (tTg) may be associated with the accumulation of extracellular matrix (ECM), both indirectly via TGF-β1 activation and directly by the formation of ε(γ-glutamyl) lysine dipeptide bonds within the ECM. The latter potentially accelerates deposition and confers the ECM with resistance to proteolytic digestion. Studied were 136 human renal biopsy samples from a range of chronic renal diseases (CRD) to determine changes in tTg and ε(γ-glutamyl) lysine crosslinking. Immunofluorescence for insoluble tTg showed a 14-fold increase in the kidneys of CRD patients (5.3 ± 0.5 versus 76 ± 54 mV/cm2), which was shown to be active by a similar 11-fold increase in the ε(γ-glutamyl) lysine crosslink (1.8 ± 0.2 versus 19.3 ± 14.2 mV/cm2). Correlations were obtained with renal function for tTg and crosslink. In situ hybridization for tTg mRNA showed that tubular epithelial cells were the major source of tTg; however, both mesangial and interstitial cells also contributed to elevated levels in CRD. This mRNA pattern was consistent with immunohistochemistry for soluble tTg. Changes in renal tTg and its product, the ε(γ-glutamyl) lysine crosslink, occur in progressive renal scarring in humans independently of the original etiology and in a similar manner to experimental models. tTg may therefore play a role in the pathogenesis of renal scarring and fibrosis in patients with CRD and can therefore be considered a potential therapeutic target.

Original languageEnglish (US)
Pages (from-to)2052-2062
Number of pages11
JournalJournal of the American Society of Nephrology
Volume14
Issue number8
DOIs
StatePublished - Aug 1 2003
Externally publishedYes

Fingerprint

Cicatrix
Kidney
Chronic Renal Insufficiency
Lysine
Extracellular Matrix
transglutaminase 2
Messenger RNA
Mesangial Cells
Dipeptides
In Situ Hybridization
Fluorescent Antibody Technique
Digestion
Fibrosis
Theoretical Models
Epithelial Cells
Immunohistochemistry
Biopsy

ASJC Scopus subject areas

  • Nephrology

Cite this

Johnson, T. S., El-Koraie, A. F., Skill, N., Baddour, N. M., El Nahas, A. M., Njloma, M., ... Griffin, M. (2003). Tissue transglutaminase and the progression of human renal scarring. Journal of the American Society of Nephrology, 14(8), 2052-2062. https://doi.org/10.1097/01.ASN.0000079614.63463.DD

Tissue transglutaminase and the progression of human renal scarring. / Johnson, Timothy S.; El-Koraie, Ahmed F.; Skill, N.; Baddour, Nahed M.; El Nahas, A. Meguid; Njloma, Melvin; Adam, Ahmed G.; Griffin, Martin.

In: Journal of the American Society of Nephrology, Vol. 14, No. 8, 01.08.2003, p. 2052-2062.

Research output: Contribution to journalArticle

Johnson, TS, El-Koraie, AF, Skill, N, Baddour, NM, El Nahas, AM, Njloma, M, Adam, AG & Griffin, M 2003, 'Tissue transglutaminase and the progression of human renal scarring', Journal of the American Society of Nephrology, vol. 14, no. 8, pp. 2052-2062. https://doi.org/10.1097/01.ASN.0000079614.63463.DD
Johnson, Timothy S. ; El-Koraie, Ahmed F. ; Skill, N. ; Baddour, Nahed M. ; El Nahas, A. Meguid ; Njloma, Melvin ; Adam, Ahmed G. ; Griffin, Martin. / Tissue transglutaminase and the progression of human renal scarring. In: Journal of the American Society of Nephrology. 2003 ; Vol. 14, No. 8. pp. 2052-2062.
@article{6e2a656a14074f7fbba96bb0b5d5a0d1,
title = "Tissue transglutaminase and the progression of human renal scarring",
abstract = "Experimental renal scarring indicates that tissue transglutaminase (tTg) may be associated with the accumulation of extracellular matrix (ECM), both indirectly via TGF-β1 activation and directly by the formation of ε(γ-glutamyl) lysine dipeptide bonds within the ECM. The latter potentially accelerates deposition and confers the ECM with resistance to proteolytic digestion. Studied were 136 human renal biopsy samples from a range of chronic renal diseases (CRD) to determine changes in tTg and ε(γ-glutamyl) lysine crosslinking. Immunofluorescence for insoluble tTg showed a 14-fold increase in the kidneys of CRD patients (5.3 ± 0.5 versus 76 ± 54 mV/cm2), which was shown to be active by a similar 11-fold increase in the ε(γ-glutamyl) lysine crosslink (1.8 ± 0.2 versus 19.3 ± 14.2 mV/cm2). Correlations were obtained with renal function for tTg and crosslink. In situ hybridization for tTg mRNA showed that tubular epithelial cells were the major source of tTg; however, both mesangial and interstitial cells also contributed to elevated levels in CRD. This mRNA pattern was consistent with immunohistochemistry for soluble tTg. Changes in renal tTg and its product, the ε(γ-glutamyl) lysine crosslink, occur in progressive renal scarring in humans independently of the original etiology and in a similar manner to experimental models. tTg may therefore play a role in the pathogenesis of renal scarring and fibrosis in patients with CRD and can therefore be considered a potential therapeutic target.",
author = "Johnson, {Timothy S.} and El-Koraie, {Ahmed F.} and N. Skill and Baddour, {Nahed M.} and {El Nahas}, {A. Meguid} and Melvin Njloma and Adam, {Ahmed G.} and Martin Griffin",
year = "2003",
month = "8",
day = "1",
doi = "10.1097/01.ASN.0000079614.63463.DD",
language = "English (US)",
volume = "14",
pages = "2052--2062",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "8",

}

TY - JOUR

T1 - Tissue transglutaminase and the progression of human renal scarring

AU - Johnson, Timothy S.

AU - El-Koraie, Ahmed F.

AU - Skill, N.

AU - Baddour, Nahed M.

AU - El Nahas, A. Meguid

AU - Njloma, Melvin

AU - Adam, Ahmed G.

AU - Griffin, Martin

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Experimental renal scarring indicates that tissue transglutaminase (tTg) may be associated with the accumulation of extracellular matrix (ECM), both indirectly via TGF-β1 activation and directly by the formation of ε(γ-glutamyl) lysine dipeptide bonds within the ECM. The latter potentially accelerates deposition and confers the ECM with resistance to proteolytic digestion. Studied were 136 human renal biopsy samples from a range of chronic renal diseases (CRD) to determine changes in tTg and ε(γ-glutamyl) lysine crosslinking. Immunofluorescence for insoluble tTg showed a 14-fold increase in the kidneys of CRD patients (5.3 ± 0.5 versus 76 ± 54 mV/cm2), which was shown to be active by a similar 11-fold increase in the ε(γ-glutamyl) lysine crosslink (1.8 ± 0.2 versus 19.3 ± 14.2 mV/cm2). Correlations were obtained with renal function for tTg and crosslink. In situ hybridization for tTg mRNA showed that tubular epithelial cells were the major source of tTg; however, both mesangial and interstitial cells also contributed to elevated levels in CRD. This mRNA pattern was consistent with immunohistochemistry for soluble tTg. Changes in renal tTg and its product, the ε(γ-glutamyl) lysine crosslink, occur in progressive renal scarring in humans independently of the original etiology and in a similar manner to experimental models. tTg may therefore play a role in the pathogenesis of renal scarring and fibrosis in patients with CRD and can therefore be considered a potential therapeutic target.

AB - Experimental renal scarring indicates that tissue transglutaminase (tTg) may be associated with the accumulation of extracellular matrix (ECM), both indirectly via TGF-β1 activation and directly by the formation of ε(γ-glutamyl) lysine dipeptide bonds within the ECM. The latter potentially accelerates deposition and confers the ECM with resistance to proteolytic digestion. Studied were 136 human renal biopsy samples from a range of chronic renal diseases (CRD) to determine changes in tTg and ε(γ-glutamyl) lysine crosslinking. Immunofluorescence for insoluble tTg showed a 14-fold increase in the kidneys of CRD patients (5.3 ± 0.5 versus 76 ± 54 mV/cm2), which was shown to be active by a similar 11-fold increase in the ε(γ-glutamyl) lysine crosslink (1.8 ± 0.2 versus 19.3 ± 14.2 mV/cm2). Correlations were obtained with renal function for tTg and crosslink. In situ hybridization for tTg mRNA showed that tubular epithelial cells were the major source of tTg; however, both mesangial and interstitial cells also contributed to elevated levels in CRD. This mRNA pattern was consistent with immunohistochemistry for soluble tTg. Changes in renal tTg and its product, the ε(γ-glutamyl) lysine crosslink, occur in progressive renal scarring in humans independently of the original etiology and in a similar manner to experimental models. tTg may therefore play a role in the pathogenesis of renal scarring and fibrosis in patients with CRD and can therefore be considered a potential therapeutic target.

UR - http://www.scopus.com/inward/record.url?scp=0041342003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041342003&partnerID=8YFLogxK

U2 - 10.1097/01.ASN.0000079614.63463.DD

DO - 10.1097/01.ASN.0000079614.63463.DD

M3 - Article

C2 - 12874459

AN - SCOPUS:0041342003

VL - 14

SP - 2052

EP - 2062

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 8

ER -